Company logo

GTG - Genetic Technologies Limited

ASX -> Healthcare -> Diagnostics & Research
Fitzroy, Australia

GTG price evolution
GTG
(in millions $) 30 Jun 2021 31 Dec 2020 30 Jun 2020 31 Dec 2019
Current assets
Cash $20.9 $32.88 $28.42 $6.56
Short term investments
Net receivables $1.07 $1.31 $0.79 $0.44
Inventory $0.08 $0.11 $0.09 $0.08
Total current assets $22.24 $18.09 $15.19 $3.97
Long term investments
Property, plant & equipment $0.64 $0.76 $0.44 $0.38
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $22.97 $18.84 $15.63 $4.34
Current liabilities
Accounts payable
Deferred revenue
Short long term debt $0.18 $0.25 $0.24 $0.22
Total current liabilities $1.41 $1.24 $1.4 $1.34
Long term debt $0.02 $0.12 $0.24 $0.14
Total noncurrent liabilities
Total debt
Total liabilities $1.44 $1.36 $1.64 $1.48
Shareholders' equity
Retained earnings -$132.04 -$129.59 -$126.12 -$124.95
Other shareholder equity
Total shareholder equity $21.53 $17.48 $13.99 $2.86
(in millions $) 30 Jun 2021 30 Jun 2020 30 Jun 2019 30 Jun 2018
Current assets
Cash $20.9 $28.42 $2.13 $5.49
Short term investments
Net receivables $1.07 $0.79 $0.82 $0.3
Inventory $0.08 $0.09 $0.03 $0.06
Total current assets $22.24 $15.19 $3.2 $5.99
Long term investments
Property, plant & equipment $0.64 $0.44 $0.07 $0.18
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $22.97 $15.63 $3.27 $6.17
Current liabilities
Accounts payable $0.59 $0.54
Deferred revenue
Short long term debt $0.18 $0.24
Total current liabilities $1.41 $1.4 $1.49 $1.45
Long term debt $0.02 $0.24
Total noncurrent liabilities
Total debt
Total liabilities $1.44 $1.64 $1.49 $1.45
Shareholders' equity
Retained earnings -$132.04 -$126.12 -$124.52 -$118.43
Other shareholder equity $0.79 $0.77
Total shareholder equity $21.53 $13.99 $1.77 $4.71
(in millions $) 30 Jun 2021 31 Dec 2020 30 Jun 2020
Revenue
Total revenue $0.1 $0.02 $0.01
Cost of revenue $0.18 $0.18 $0.06
Gross Profit -$0.07 -$0.17 -$0.05
Operating activities
Research & development $2.05 $1.06 $1.35
Selling, general & administrative $2.06 $3.22 $2.67
Total operating expenses $3.7 $3.48 $3.65
Operating income -$3.6 -$3.47 -$3.64
Income from continuing operations
EBIT
Income tax expense
Interest expense -$0.06 -$0.22 $0.21
Net income
Net income -$3.6 -$3.48 -$3.65
Income (for common shares) -$3.6 -$3.48 -$3.65
(in millions $) 30 Jun 2021 30 Jun 2020 30 Jun 2019 30 Jun 2018
Revenue
Total revenue $0.12 $0.01 $0.03 $0.19
Cost of revenue $0.31 $0.23 $0.28 $0.3
Gross Profit -$0.19 -$0.22 -$0.25 -$0.11
Operating activities
Research & development $3.11 $2.48 $2.36 $2.21
Selling, general & administrative $5.26 $4.66 $4.41 $4.21
Total operating expenses $7.18 $6.29 $6.43 $5.65
Operating income -$7.06 -$6.28 -$6.41 -$5.46
Income from continuing operations
EBIT
Income tax expense
Interest expense $0.02 $0.04 -$0.09 -$0.11
Net income
Net income -$7.08 -$6.29 -$6.43 -$5.46
Income (for common shares) -$7.08 -$6.29 -$6.43 -$5.46